Drugs - Drugs Xagena

Drugs

Home Page

Xagena Medicine

Xagena.net

Emsam is the first transdermal patch for depression

Emsam is the first transdermal patch for depression

Vivitrol for treatment of alcohol-dependent patients, approved

Macugen: rare cases of anaphylaxis/anaphylactoid reactions

Sepsis associated with Mifeprex for medical abortion

Tequin associated with hypoglycemia and hyperglycemia

Hepatotoxity linked to Tracleer

Mobic linked to higher risk of adverse cardiovascular events than Celebrex and Vioxx

Paroxetine: increased risk of suicidal behavior in young adults

FDA has approved Chantix for smoking cessation

Azilect, a new treatment for Parkinson's Disease

Evista associated with increased risk of stroke mortality in postmenopausal women at increased risk for cardiovascular disease

Acetylsalicylic Acid reduces cardiovascular risks in men and women, but differently

Antibiotic Ketek linked to two cases of liver failure and implicated in a third case of hepatitis

Effectiveness of Fentanyl lozenges for breakthrough cancer pain

Advanced cervical cancer: FDA has approved a combination of Hycamtin and Cisplatin

Seasonal affective disorder: FDA has approved Wellbutrin XL

Wet age-related macular degeneration: FDA has approved Lucentis

Parkinson’s disease: Exelon for treatment of dementia

HIV-1 infection: FDA has approved Atripla, an once-a-day three-drug combination

Wet age-related macular degeneration: FDA has approved Lucentis

Bismacine may cause serious adverse events

Thrombolitic therapy before angioplasty or stent placement not beneficial for myocardial infarction patients

Morphine and topical Tetracaine found effective in treating pain in newborn infants

Sensible metabolic differences in how adults, infants and children process drugs

Raloxifene as effective as Tamoxifen in preventing invasive breast cancer

NICE: inhaled Insulin is not recommended for the treatment of type 1 or type 2 diabetes mellitus ( preliminary recommendations )

FDA has approved Dacogen for treatment of myelodysplastic syndromes

EU: Herceptin for early-stage in HER2-positive breast cancer approved

Relapsing multiple sclerosis: FDA has approved the reintroduction of Tysabri

Next Pages 1 2 3 4 [5] 6 7 8 9

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions